baber/WOPTO huggingface dataset:
Patent EP-3436126-A2 (EP)
Inventor: O'BRYAN JEFFREY C
IPC: A61M25/06
Filed: 2017-03-17
Abstract: La présente invention concerne un système de cathéter intraveineux (IV) qui peut comprendre un composant cathéter ayant un moyeu de cathéter, une canule s'étendant dans le sens distal à partir du moyeu de cathéter, et une plateforme de fixation. La plateforme de fixation peut comprendre une aile qui peut s'étendre à partir du moyeu de cathéter. Le système de cathéter IV peut également comprendre un composant aiguille doté d'un moyeu d'aiguille, une aiguille s'étendant dans le sens distal depuis le moyeu d'aiguille le long d'un axe, et une poignée s'étendant depuis le moyeu d'aiguille. La poignée peut être généralement parallèle à l'axe et disposée sur un côté du moyeu d'aiguille. L'aile et la poignée peuvent être positionnées pour faciliter une manipulation avec une seule main en vue de déplacer le système de cathéter IV d'une configuration d'introduction à une configuration de distribution de fluide.
Patent EP-3520293-A2 (EP)
Inventor: WANG RENQIU
IPC: H04L5/00
Filed: 2017-09-25
Abstract: Various additional and alternative aspects are described herein. In some aspects, the present disclosure provides a method for wireless communication. The method includes determining at least one RS pattern for allocating a reference signal on an uplink channel and a downlink channel based on one or more transmission factors for transmitting the reference signal, wherein at least a portion of the at least one RS pattern is the same for the uplink channel and the downlink channel. The method further includes transmitting the reference signal using the determined RS pattern.
Patent EP-3399945-A2 (EP)
Title: Dispositifs d'encapsulation implantables
Inventor: CULLY EDWARD H
IPC: A61M31/00
Filed: 2017-11-08
Abstract: La présente invention concerne des dispositifs d'encapsulation implantables destiné à contenir un élément biologique ou un dispositif thérapeutique qui contient un élément biologique. En particulier, des aspects de la présente invention concernent un appareil implantable qui comprend une extrémité distale, une extrémité proximale, un collecteur comprenant au moins un orifice d'accès placé soit à l'extrémité distale soit à l'extrémité proximale, et une pluralité de tubes de contention fixés au collecteur et en communication fluidique avec le ou les orifices d'accès. En outre, le dispositif d'encapsulation peut contenir un orifice de rinçage et un tube qui sont en communication fluidique avec le collecteur. Les tubes de contention peuvent contenir un élément biologique (par exemple, des cellules) ou un dispositif thérapeutique (par exemple un élément d'encapsulation de cellule).
Patent EP-3545014-A2 (EP)
Inventor: AVRAMIDIS KOSTAS S
IPC: C09J151/08
Filed: 2017-11-21
Abstract: The present disclosure relates to compositions comprising a copolymer derived from a vinyl aromatic monomer, a (meth)acrylate monomer, an acid monomer, and a copolymerizable surfactant and compositions comprising the same. The (meth)acrylate monomer can be selected from a monomer having a theoretical glass transition temperature (Tg) for its corresponding homopolymer of 0°C or less or a hydrophobic (meth)acrylate monomer. In some embodiments, the copolymer is further derived from an organosilane. The copolymers can have a theoretical glass transition temperature (Tg) from -60°C to 80°C and a number average particle size of 250 nm or less. The compositions can be used to prepare compositions such as coatings that have improved water resistance, blush resistance, and/or resistance to hydrostatic pressures. Methods of making the copolymers are also provided.
Patent EP-3381435-A2 (EP)
Inventor: KAKINUMA HIROAKI
IPC: A61K6/00
Filed: 2018-03-29
Abstract: A dental adhesive agent includes a polymerizable monomer; first and second inorganic particles which have been subjected to a surface treatment by a chemical compound, respectively; and a third inorganic particle. The first inorganic particle has a volume median diameter greater than or equal to 0.1 µm and less than or equal to 0.5 µm, the second inorganic particle has a volume median diameter greater than or equal to 0.6 µm and less than or equal to 0.9 µm, and the third inorganic particle has a mean primary-particle diameter greater than or equal to 5 nm and less than or equal to 50 nm. The mass ratio of the third inorganic particle with respect to the gross mass of the first inorganic particle, the second inorganic particle and the third inorganic particle is greater than or equal to 0.001 and less than or equal to 0.05.
Patent EP-3470892-A2 (EP)
Inventor: TAO YUKIHIRO
IPC: G02B5/02
Filed: 2018-09-12
Abstract: A screen 20 as a transparent screen has an anisotropy. The screen has a first scattering layer 24 disposed on a side of a first surface thereof and exhibiting scattering. The screen has a second scattering layer 27 disposed on a side of a second surface 22 thereof as a rear side of the first surface 21. When the screen 20 is disposed so as to be directed perpendicularly and exhibit the anisotropy in upward and downward directions, light 28b entering into a surface of the second scattering layer 27 facing the first surface 21 from an upward direction is scattered more strongly than light 28a entering into the surface of the second scattering layer 27 facing the first surface 21 from a lateral direction in the second scattering layer 27.
Patent EP-3447927-A2 (EP)
Inventor: PICARD GILLES
IPC: H04B1/7143
Filed: 2015-01-13
Abstract: Techniques for frequency-hopping sequence-generation are described herein. In one example, a sequence of pseudo random numbers may be used to generate a scrambling sequence. The scrambling sequence may be used to map an unscrambled sequence of channels into a scrambled sequence of channels. The scrambling sequence may be based on a Galois field. Channel whitening may be performed to reduce channel overuse. The scrambled sequence of channels may be provided to a radio to enable the radio to tune to the channels indicated by the scrambled sequence of channels.
Patent EP-3645917-A2 (EP)
Title: Control element for a vehicle
Inventor: EICHHORN JULIAN
IPC: F16H59/10
Filed: 2018-05-30
Abstract: The invention relates to a control element (102) for a vehicle (100). The control element (102) is designed to change between a parking state (210) and a driving state (220). In the parked state (210), the control element (102) is designed to enable a driver to switch the vehicle (100) from a parked state to a travel state. Said control element (102) also enables the vehicle driver (100) to freely select a gear (221) of the vehicle (100) by changing from a parking state (210) into a drive state (220).
Patent EP-3600357-A2 (EP)
Inventor: LYNN RACHEL
IPC: C07K14/00
Filed: 2018-03-30
Abstract: The present invention relates to T cell compositions and methods of using the same in the context of therapy and treatment. In particular, the invention provides chimeric antigen receptor (CAR) T cells that are modified to maintain functionality under conditions in which unmodified CAR T cells display exhaustion. Compositions and methods disclosed herein find use in inhibiting or reversing CAR T cell exhaustion (e.g., by modulating CAR surface expression) thereby enhancing CAR T cell function. Compositions and methods of the invention find use in both clinical and research settings, for example, within the fields of biology, immunology, medicine, and oncology.
Patent EP-3560144-A2 (EP)
Title: Blockchain data protection based on generic account model and homomorphic encryption
Inventor: ZHANG WENBIN
IPC: H04L9/32
Filed: 2018-12-21
Abstract: Implementations of the specification include receiving transaction data associated with the transaction, the transaction data comprising: data representative of a plurality of assets, a first commitment that hides a first random number and a transaction amount of the transaction, a second commitment that hides a second random number and a change, the transaction amount and a third random number both encrypted by a public key of the second node based on a linear deterministic homomorphic encryption (HE) scheme, the change and a fourth random number both encrypted by a public key of the first node based on the linear deterministic HE scheme, and a zero-knowledge proof (ZKP); determining, based on the ZKP, whether the transaction is valid based on determining if the first random number is equal to the third random number, the second random number is equal to the fourth random number, and the transaction amount hidden in the first commitment is equal to the transaction amount encrypted by the public key of the second node.
Patent EP-3581653-A2 (EP)
Inventor: ROTHMAN JEFFREY K
IPC: C12N15/11
Filed: 2014-12-17
Abstract: The present invention provides compositions and methods for treating cancer with peptide nucleic acid agents. In some embodiments, the present invention provides methods and compositions relating to peptide nucleic acid agents that target oncogenes. For example, the present invention provides compositions, including pharmaceutical compositions, comprising agents specific for BRAF V600E inhibition, or fragments or characteristic portions thereof. The present invention further provides various therapeutic and/or diagnostic methods of using BRAF V600E specific peptide nucleic acid agents and/or compositions.
Patent EP-3867964-A2 (EP)
Title: Battery cell interconnect system
Inventor: KENNEDY CRAIG
IPC: H01M50/569
Filed: 2019-10-15
Abstract: A battery module having a plurality of battery cells disposed in a housing and interconnected by upper and lower interconnect panels stamped from sheets of conductive metal. Each of the upper and lower interconnect panels have a plurality of contacts secured to terminals of the battery cells, respectively. The contacts are at least partially disposed in panel openings extending through the upper and lower interconnect panels. A carrier is provided and includes a lead frame molded into a body of thermoplastic resin. The lead frame connects a plurality of locations on the upper and lower interconnect panels to a monitoring module that measures physical properties at the locations.
Patent EP-3832465-A2 (EP)
Inventor: THOMAS RENJI
IPC: G06F9/50
Filed: 2020-09-22
Abstract: An apparatus comprising: a model to generate adjusted tuning parameters of a thread scheduling policy based on a tradeoff indication value of a target system; and a workload monitor to: execute a workload based on the thread scheduling policy; obtain a performance score and a power score from the target system based on execution of the workload, the performance score and the power score corresponding to a tradeoff indication value; compare the tradeoff indication value to a criterion; and based on the comparison, initiate the model to re-adjust the adjusted tuning parameters.
Patent EP-4087601-A2 (EP)
Inventor: HORVATINOVICH JOSEPH
IPC: C12N5/0781
Filed: 2021-01-08
Abstract: La présente invention concerne des méthodes de traitement d'une tumeur (par exemple, le cancer des cellules rénales) par l'administration d'une immunothérapie comprenant des cellules dendritiques chargées d'ARN codant pour un antigène tumoral et un produit pharmaceutique qui peut diminuer les taux d'IgG circulantes, bloquer l'activation médiée par les IgG des lymphocytes T CD16+, diminuer la concentration et/ou la fonction des lymphocytes B, réduire la fréquence des lymphocytes B CD38+ TGF-β+, diminuer la sécrétion par les lymphocytes B du TGF-β, et/ou maintenir la fréquence des lymphocytes T CD25+CD28+ CD4 et/ou CD8.
Patent EP-4164689-A2 (EP)
Title: Procédés et compositions de prévention du diabète de type 1
Inventor: LEON FRANCISCO
IPC: A61P3/10
Filed: 2021-06-11
Abstract: L'invention porte, dans un aspect, sur un procédé de prévention ou de retardement de l'apparition du diabète de type 1 clinique (T1D), consistant : à fournir un sujet non diabétique qui est à risque pour le T1D ; à administrer une quantité thérapeutiquement efficace d'un anticorps anti-CD3 au sujet non diabétique ; et à déterminer, avant ou après l'étape d'administration, que le sujet non diabétique présente plus d'environ 5 % à plus d'environ 10 % de lymphocytes T TIGIT+KLRG1+CD8+ dans tous les lymphocytes CD3+, qui indique la prévention réussie ou le retard réussi de l'apparition du T1D clinique.
Patent EP-4271953-A2 (EP)
Inventor: BERRA MATTEO
IPC: F25J3/04
Filed: 2021-12-27
Abstract: La présente invention concerne un système de stockage ou de production d'électricité, permettant la stabilisation du réseau électrique dans des conditions de disponibilité excessive d'électricité ou de manque d'électricité et permettant éventuellement la production de gaz naturel liquéfié.
Patent EP-4263591-A2 (EP)
Inventor: JANLE RAHUL DNYANDEO
IPC: C07K14/71
Filed: 2021-12-15
Abstract: Provided herein are liquid pharmaceutical compositions comprising: a fusion protein that comprises a targeting moiety and an immunomodulatory moiety, wherein: i) said targeting moiety specifically binds human epidermal growth factor receptor (hEGFR); and (ii) said immunomodulatory moiety comprises an amino acid sequence of the extracellular domain of human transforming growth factor-beta receptor H (hTGFpRII); a buffer present at a concentration from about 5 mM to about 30 mM; and a tonifying agent present at a concentration from about 4% w/v to about 10% w/v; wherein said liquid pharmaceutical composition has a pH of from about 5.5 to about 7.0. Also provided herein are methods of preparing liquid pharmaceutical composition comprising fusion proteins, and methods of use in treating cancer.
Patent EP-4152047-A2 (EP)
Inventor: SHAND MARK ALEXANDER
IPC: G05D1/02
Filed: 2018-06-06
Abstract: A computing system may operate a LIDAR device to emit light pulses in accordance with a time sequence including a time-varying dither. The system may then determine that the LIDAR detected return light pulses during corresponding detection periods for each of two or more emitted light pulses. Responsively, the system may determine that the detected return light pulses have (i) detection times relative to corresponding emission times of a plurality of first emitted light pulses that are indicative of a first set of ranges and (ii) detection times relative to corresponding emission times of a plurality of second emitted light pulses that are indicative of a second set of ranges. Given this, the system may select between using the first set of ranges as a basis for object detection and using the second set of ranges as a basis for object detection, and may then engage in object detection accordingly.
Patent EP-4234474-A2 (EP)
Inventor: DAVIS DANIEL B
IPC: B66D5/18
Filed: 2017-11-16
Abstract: A method is disclosed of retrofitting an elevator machine with primary and secondary braking, the machine being disposed on a machine support frame in an elevator machine room, and engaging one or more ropes for providing selective movement of an elevator car disposed in an elevator shaft, the machine having a drive sheave including a cylindrical brake drum, and brake components including dual brake arms; the method including: removing the brake components; affixing flanged disc segments about the drum and interlocking the flanged disc segments to form a brake rotor; and mounting respective brake calipers to frame mounts for providing primary and secondary braking to the elevator machine.
Patent EP-4312384-A2 (EP)
Inventor: SHEN XIAOMAN
IPC: H04B7/024
Filed: 2023-07-10
Abstract: A communication method, a communication apparatus, and a computer-readable storage medium are disclosed, to increase an effective area for spatial reuse and improve a system capacity. The method includes: A sharing AP selects a first beam width used to schedule a sharing STA during coordinated transmission, and the sharing AP sends a coordinated transmission notification to a shared AP, where the coordinated transmission notification includes a coordinated transmission parameter, the coordinated transmission parameter is obtained based on the sharing STA and the first beam width, the coordinated transmission notification indicates the shared AP to select, based on the coordinated transmission parameter, a shared STA and a second beam width that are used for coordinated transmission, the second beam width is one of adjustable beam widths of the shared AP, and the first beam width is one of at least two adjustable beam widths of the sharing AP.
Patent EP-4273268-A2 (EP)
Inventor: LITTLEJOHN MATHEW DOUGLAS
IPC: C12Q1/6876
Filed: 2014-10-24
Abstract: The present invention relates, inter alia, to methods for determining whether or not an animal and/or its offspring is more likely than not to have an increased tolerance to heat, an increased resistance to ticks, and/or a desirable coat texture. It also provides methods for selecting or rejecting animals, one or more cells or embryos, estimating the worth of an animal, generating animals having a desired genotype/phenotype, cloning and breeding animals and herd formation.
Patent EP-4296257-A2 (EP)
Title: Process of preparing a peptide epoxyketone immunoproteasome inhibitor
Inventor: JOHNSON HENRY
IPC: C07C69/612
Filed: 2017-06-29
Abstract: Disclosed herein are methods for preparing [(2S,3R)-N-[(2S)-3-(cyclopent-1-en-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[(2(S)-2-[2-(morpholin-4-yl)acetamido]propanamido]propanamide (compound "G"):and precursors thereof.
Patent EP-4303312-A2 (EP)
Inventor: VACIC ALEKSANDAR
IPC: C12Q1/18
Filed: 2017-04-21
Abstract: In some aspects, automated rapid antimicrobial susceptibility testing systems for performing a multi-assay testing sequence can include an automated incubation assembly having a nest assembly adapted to house at least one test panel having a plurality of wells for receiving a sample comprising microorganisms originating from a clinical sample, the incubation assembly facilitating incubation of one or more test panels in order to undergo the multi-assay testing sequence; a robotic handling assembly configured to accept one or more incoming test panels and move them to and from the incubation assembly for incubation between each assay of the multi-assay testing sequence; an automated liquid handling assembly configured to exchange one or more fluids in the plurality of wells of the test panels; and an optical assembly for interrogation and readout of each assay of the multi-assay testing sequence being performed in the plurality of wells.
Patent EP-4295792-A2 (EP)
Inventor: DOLAN FINBAR
IPC: A61B17/3207
Filed: 2020-11-06
Abstract: An elongate endovascular element for crossing through an obstruction in a blood vessel comprises: a proximal section; a distal tip section of smaller diameter than the proximal section; and a distally-tapering intermediate section extending between the proximal and distal tip sections; wherein the tapered intermediate section has a length that is substantially λ/2 or a multiple of λ/2, where λ is a wavelength of a driving frequency that will produce longitudinal resonance in the element.
Patent EP-4269053-A2 (EP)
Inventor: SORIA PERUJO JOSE LUIS
IPC: B26F1/40
Filed: 2020-10-29
Abstract: Die Erfindung betrifft eine Bogenbearbeitungsmaschine (01) umfassend zumindest ein Formgebungsaggregat (300) und zumindest ein Ausbrechaggregat (400), wobei die Bogenbearbeitungsmaschine (01) zumindest einen Antrieb (1001) aufweist, wobei das zumindest eine Ausbrechaggregat (400) zumindest ein Ausbrechwerk (401) aufweist, wobei das zumindest eine Ausbrechwerk (401) zumindest ein als oberes Ausbrechwerkzeug (402) ausgebildetes Werkzeug (402) und zumindest ein als unteres Ausbrechwerkzeug (403) ausgebildetes Werkzeug (403) umfasst, wobei der zumindest eine Antrieb (1001) über zumindest ein Getriebe (1007) zumindest ein Ausbrechwerkzeug (402; 403) des zumindest einen Ausbrechwerks (401) des zumindest einen Ausbrechaggregats (400) antreibend ausgebildet ist, wobei das zumindest eine Getriebe (1007) zumindest zwei Stirnräder (1009; 1011; 1012; 1013; 1021) umfasst, wobei zumindest ein nachgelagertes Getriebe (1019) nach dem zumindest einen Getriebe (1007) angeordnet ist, wobei das zumindest eine nachgelagerte Getriebe (1019) mit dem zumindest einen Ausbrechwerkzeug (402; 403) des zumindest einen Ausbrechaggregats (400) gekoppelt ist, wobei das zumindest eine nachgelagerte Getriebe (1019) zumindest eine rotative Bewegung in zumindest eine wechselseitige Bewegung umwandelnd ausgebildet ist, wobei zwischen dem zumindest einen nachgelagerten Getriebe (1019) und dem zumindest einen Ausbrechwerkzeug (402; 403) zumindest ein Übertragungselement (1026; 1027; 1028; 1029) angeordnet ist, wobei das zumindest eine obere Ausbrechwerkzeug (402) mit dem zumindest einen Übertragungselement (1028) über zumindest einen Bewegungswandler (1031) gekoppelt ist. Die Erfindung betrifft zudem ein Verfahren zum Antreiben zumindest eines Werkzeugs (402; 403) einer Bogenbearbeitungsmaschine (01).
Patent EP-4292420-A2 (EP)
Title: Autonomes landwirtschaftliches trägerfahrzeug
Inventor: HORSCH MICHAEL
IPC: A01D34/00
Filed: 2019-04-04
Abstract: Es ist ein autonomes landwirtschaftliches Trägerfahrzeug (10), zum Tragen von zumindest einem landwirtschaftlichen Arbeitsgerät (24) offenbart, mit einer Rahmenkonstruktion (20), und einem an der Rahmenkonstruktion (20) angebrachten Fahrwerk (12), wobei das Fahrwerk (12) zumindest zwei lenkbare Räder und/oder Raupenfahrwerke (14) aufweist, wobei der Rahmenkonstruktion (20) zumindest eine Montagevorrichtung (22) zur Verbindung mit dem zumindest einem landwirtschaftlichen Arbeitsgerät (24) zugeordnet ist, und mit einer Umfeldsensorik (40) zur Ermittlung von im Umfeld des Trägerfahrzeug (10) vorhandenen Hindernissen und/oder Elementen, sowie mit einer Steuereinrichtung (36) zum Steuern des Trägerfahrzeug (10) und/oder des zumindest einen Arbeitsgerät (24), wobei die Steuereinrichtung (36) mit einem, eine Position erfassenden und/oder ausgebenden Positionsbestimmungssystem (38) verbindbar ist, um ein autonomes landwirtschaftliches Trägerfahrzeug (10) zu schaffen, bei welchem die Schlagkraft nicht verringert wird, kein zusätzliches Zugfahrzeug für die Arbeitsgeräte (24) benötigt wird, und darüber hinaus keine Bedienperson während einer Feldarbeit zwingend erforderlich ist vorgesehen, dass in der Steuereinrichtung (36) vorzugsweise positionsabhängige Arbeitsanweisungen für das Trägerfahrzeug (10) hinterlegt sind.Die Erfindung betrifft zudem ein Verfahren zur Steuerung und/oder Regelung eines autonomen Trägerfahrzeugs.
Patent EP-0030019-A2 (EP)
Inventor: HAZAN ISIDOR
IPC: C08G81/02
Filed: 1980-11-28
Abstract: A polyamine/epoxy ether graft copolymer having an acrylic polamine backbone with secondary amine and hydroxy functionality, part of which is terminal primary hydroxy groups, onto which is grafted an epoxy ether. The ether is an epoxy resin preferably reacted with nonylphenol resulting in a monoepoxide ether with one or less epoxy group per epoxy ether molecule. The ether is reacted with part of the secondary amine on the acrylic backbone. This system can be formulated to a nearly-neutral pH cathodic dispersion with good cure response at 150-175°C using conventional aminoplast crosslinkers.
Patent EP-0028092-A2 (EP)
Inventor: BURCHIEL SCOTT W
IPC: A61K39/395
Filed: 1980-10-14
Abstract: T-99m labeled antibody compositions and kits for preparing them and using them for in vivo diagnostic purposes are provided. Cancer or tumor sites producing hCG or hCG-derivatives are detected by scintigraphy, after administering anti-hCG or anti-hCG derivatives, by administering an antibody composition specific to the anti-hCG or its derivatives, the said antibody composition being tagged with one of the labeling isotopes. To increase sensitivity of detection, extra sites for the labeled composition can be obtained by administering an unlabeled antibody composition specific to the anti-hCG or its derivatives, followed by a second antibody composition specific to the first antibody, the second antibody composition being tagged with one of the labeling isotopes.